March 21, 2018 / 12:20 PM / a month ago

BRIEF-Helix Biopharma Signs Agreement With Promab Biotechnologies To Co-Develop Car-T For Hematological Malignancies

March 21 (Reuters) - Helix Biopharma Corp:

* HELIX BIOPHARMA CORP. SIGNS COLLABORATION AGREEMENT WITH PROMAB BIOTECHNOLOGIES TO CO-DEVELOP CAR-T FOR HEMATOLOGICAL MALIGNANCIES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below